MabSpace Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Merger of Eq.

MabSpace Biosciences General Information

Description

Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and liver. The company's therapeutics are based on its proprietary immune tolerance breaking technology (IMBT) that generates lead antibodies with diverse epitopes that targets different components of the tumor microenvironment, enabling physicians to treat cancer and fibrotic diseases with a better medical outcome.

Contact Information

Website
www.mabspacebio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Room B6-501, Bio-Nano Park
  • No.218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Transcenta Holding
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room B6-501, Bio-Nano Park
  • No.218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MabSpace Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger of Equals 02-Jan-2019 Completed Generating Revenue
2. Early Stage VC (Series B1) 09-Feb-2018 Completed Generating Revenue
1. Early Stage VC (Series A2) 28-Aug-2015 $13M $13M Completed Generating Revenue
To view MabSpace Biosciences’s complete valuation and funding history, request access »

MabSpace Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and live
Drug Discovery
Suzhou, China
60 As of 2019

Cambridge, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MabSpace Biosciences Competitors (87)

One of MabSpace Biosciences’s 87 competitors is Repertoire Immune Medicines, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Repertoire Immune Medicines Venture Capital-Backed Cambridge, MA
Marengo Therapeutics Venture Capital-Backed Cambridge, MA
Ayala Pharmaceuticals Corporation Wilmington, DE
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 87 competitors. Get the full list »

MabSpace Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MabSpace Biosciences Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
HSG (Hong Kong) Venture Capital Minority
King Star Capital Venture Capital Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Teng Yue Partners Hedge Fund Minority
To view MabSpace Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

MabSpace Biosciences FAQs

  • When was MabSpace Biosciences founded?

    MabSpace Biosciences was founded in 2012.

  • Where is MabSpace Biosciences headquartered?

    MabSpace Biosciences is headquartered in Suzhou, China.

  • What is the size of MabSpace Biosciences?

    MabSpace Biosciences has 60 total employees.

  • What industry is MabSpace Biosciences in?

    MabSpace Biosciences’s primary industry is Drug Discovery.

  • Is MabSpace Biosciences a private or public company?

    MabSpace Biosciences is a Private company.

  • What is MabSpace Biosciences’s current revenue?

    The current revenue for MabSpace Biosciences is .

  • How much funding has MabSpace Biosciences raised over time?

    MabSpace Biosciences has raised $53M.

  • Who are MabSpace Biosciences’s investors?

    HSG (Hong Kong), King Star Capital, LAV (Lilly Asia Fund), and Teng Yue Partners have invested in MabSpace Biosciences.

  • Who are MabSpace Biosciences’s competitors?

    Repertoire Immune Medicines, Marengo Therapeutics, Ayala Pharmaceuticals, Inovio Pharmaceuticals, and Intellia Therapeutics are some of the 87 competitors of MabSpace Biosciences.

  • When was MabSpace Biosciences acquired?

    MabSpace Biosciences was acquired on 02-Jan-2019.

  • Who acquired MabSpace Biosciences?

    MabSpace Biosciences was acquired by Transcenta Holding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process